Keyphrases
5-fluorouracil (5-FU)
16%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
6%
Bolus
8%
Cancer Patients
14%
Chemoradiation
16%
Chemoradiotherapy
19%
Chemotherapy
23%
Cisplatin
9%
Combined Modality Therapy
6%
Complete Response
9%
Computed Tomography
7%
Concurrent Chemoradiotherapy
21%
Disease Control
8%
Dose-volume Histogram
8%
Dysphagia
8%
Failure Pattern
8%
Fluorouracil
17%
Head-and-neck
26%
Head-and-neck Cancer
100%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
8%
Histogram Analysis
13%
Hydroxyurea
16%
Hyperthermia
18%
IMRT Plan
6%
Induction Chemotherapy
22%
Intensity-modulated Radiation Therapy
9%
Intensity-modulated Radiotherapy
8%
Irradiation
15%
Locoregional Control
9%
Locoregionally Advanced
16%
Mucositis
10%
NCCN Guidelines
11%
Organ Preservation
6%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
17%
Overall Survival
11%
Paclitaxel
13%
Phase II Trial
10%
Progression-free Survival
14%
Radiation Dose
14%
Radiation Oncology
16%
Radiation Therapy
46%
Radiotherapy
27%
Seminoma
8%
Squamous Cell Carcinoma of Head
6%
Survival Rate
6%
Swallowing Function
13%
Total Lymphoid Irradiation
6%
Tumor
23%
Twice Daily
9%
Xerostomia
8%
Medicine and Dentistry
Basal-Cell Carcinoma
6%
Brachytherapy
6%
Cancer
9%
Carcinoma
7%
Chemoradiotherapy
32%
Cisplatin
7%
Clinical Trial
5%
Computer Assisted Tomography
7%
Diseases
31%
Dose-Volume Histogram
11%
External Beam Radiotherapy
5%
Fluorouracil
13%
Head and Neck Cancer
80%
Head and Neck Squamous Cell Carcinoma
5%
Hodgkin's Lymphoma
7%
Hydroxyurea
5%
Hyperthermia
6%
Induction Chemotherapy
15%
Intensity Modulated Radiation Therapy
18%
Laryngeal Cancer
5%
Larynx
15%
Larynx Carcinoma
6%
Lymph Node Irradiation
6%
Malignant Neoplasm
11%
Multivariate Analysis
5%
Neck
23%
Neck Dissection
5%
Neoplasm
29%
Oropharynx Carcinoma
8%
Overall Survival
12%
Paclitaxel
5%
Pharynx
5%
Plummer-Vinson Syndrome
12%
Progression Free Survival
10%
Radiation Oncology
15%
Radiation Therapy
73%
Recurrent Disease
9%
Second Cancer
5%
Seminoma
5%
Skin Carcinoma
5%
Squamous Cell
6%
Squamous Cell Carcinoma
8%
Survival Rate
8%
Swallowing Function
7%
Tongue
12%
Treatment Planning
5%
Xerostomia
8%